Logo image of IDIP.PA

IDI (IDIP.PA) Stock Fundamental Analysis

EPA:IDIP - FR0000051393 - Common Stock

78.2 EUR
-1.2 (-1.51%)
Last: 8/22/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, IDIP scores 4 out of 10 in our fundamental rating. IDIP was compared to 112 industry peers in the Capital Markets industry. IDIP has an excellent financial health rating, but there are some minor concerns on its profitability. IDIP has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

IDIP had positive earnings in the past year.
In the past year IDIP has reported a negative cash flow from operations.
IDIP had positive earnings in each of the past 5 years.
In the past 5 years IDIP always reported negative operating cash flow.
IDIP.PA Yearly Net Income VS EBIT VS OCF VS FCFIDIP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

The Return On Assets of IDIP (2.48%) is better than 61.61% of its industry peers.
Looking at the Return On Equity, with a value of 2.81%, IDIP is in line with its industry, outperforming 41.96% of the companies in the same industry.
IDIP has a Return On Invested Capital (1.60%) which is in line with its industry peers.
IDIP had an Average Return On Invested Capital over the past 3 years of 5.26%. This is below the industry average of 8.47%.
Industry RankSector Rank
ROA 2.48%
ROE 2.81%
ROIC 1.6%
ROA(3y)6.91%
ROA(5y)8.52%
ROE(3y)8.14%
ROE(5y)10.26%
ROIC(3y)5.26%
ROIC(5y)6.74%
IDIP.PA Yearly ROA, ROE, ROICIDIP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

With an excellent Profit Margin value of 55.88%, IDIP belongs to the best of the industry, outperforming 91.07% of the companies in the same industry.
In the last couple of years the Profit Margin of IDIP has declined.
Looking at the Operating Margin, with a value of 48.06%, IDIP belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
IDIP's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 79.62%, IDIP is in the better half of the industry, outperforming 77.68% of the companies in the same industry.
IDIP's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 48.06%
PM (TTM) 55.88%
GM 79.62%
OM growth 3Y-18.32%
OM growth 5Y-8%
PM growth 3Y-13.5%
PM growth 5Y-3.2%
GM growth 3Y-6.56%
GM growth 5Y-3.38%
IDIP.PA Yearly Profit, Operating, Gross MarginsIDIP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

7

2. Health

2.1 Basic Checks

Compared to 1 year ago, IDIP has about the same amount of shares outstanding.
IDIP has less shares outstanding than it did 5 years ago.
The debt/assets ratio for IDIP has been reduced compared to a year ago.
IDIP.PA Yearly Shares OutstandingIDIP.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
IDIP.PA Yearly Total Debt VS Total AssetsIDIP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

IDIP has an Altman-Z score of 4.84. This indicates that IDIP is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 4.84, IDIP belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
IDIP has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.08, IDIP is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 4.84
ROIC/WACCN/A
WACCN/A
IDIP.PA Yearly LT Debt VS Equity VS FCFIDIP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

IDIP has a Current Ratio of 8.07. This indicates that IDIP is financially healthy and has no problem in meeting its short term obligations.
IDIP has a better Current ratio (8.07) than 94.64% of its industry peers.
IDIP has a Quick Ratio of 8.07. This indicates that IDIP is financially healthy and has no problem in meeting its short term obligations.
IDIP's Quick ratio of 8.07 is amongst the best of the industry. IDIP outperforms 94.64% of its industry peers.
Industry RankSector Rank
Current Ratio 8.07
Quick Ratio 8.07
IDIP.PA Yearly Current Assets VS Current LiabilitesIDIP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1

3. Growth

3.1 Past

IDIP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -73.00%.
IDIP shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.38% yearly.
The Revenue for IDIP has decreased by -60.84% in the past year. This is quite bad
The Revenue has been decreasing by -6.78% on average over the past years.
EPS 1Y (TTM)-73%
EPS 3Y-46.57%
EPS 5Y-9.38%
EPS Q2Q%302.61%
Revenue 1Y (TTM)-60.84%
Revenue growth 3Y-37.88%
Revenue growth 5Y-6.78%
Sales Q2Q%45877.08%

3.2 Future

The Earnings Per Share is expected to grow by 1.60% on average over the next years.
The Revenue is expected to decrease by -11.47% on average over the next years. This is quite bad
EPS Next Y4.01%
EPS Next 2Y3.51%
EPS Next 3Y1.6%
EPS Next 5YN/A
Revenue Next Year15.53%
Revenue Next 2Y10.61%
Revenue Next 3Y-11.47%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IDIP.PA Yearly Revenue VS EstimatesIDIP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
IDIP.PA Yearly EPS VS EstimatesIDIP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8 10

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 28.64, the valuation of IDIP can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as IDIP.
When comparing the Price/Earnings ratio of IDIP to the average of the S&P500 Index (27.24), we can say IDIP is valued inline with the index average.
With a Price/Forward Earnings ratio of 7.43, the valuation of IDIP can be described as very cheap.
Based on the Price/Forward Earnings ratio, IDIP is valued cheaper than 98.21% of the companies in the same industry.
IDIP is valuated cheaply when we compare the Price/Forward Earnings ratio to 35.82, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 28.64
Fwd PE 7.43
IDIP.PA Price Earnings VS Forward Price EarningsIDIP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IDIP is valued a bit cheaper than 66.96% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 26.09
IDIP.PA Per share dataIDIP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IDIP does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)7.13
PEG (5Y)N/A
EPS Next 2Y3.51%
EPS Next 3Y1.6%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.53%, IDIP has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 5.70, IDIP pays a bit more dividend than its industry peers.
IDIP's Dividend Yield is rather good when compared to the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 3.53%

5.2 History

On average, the dividend of IDIP grows each year by 32.69%, which is quite nice.
Dividend Growth(5Y)32.69%
Div Incr Years2
Div Non Decr Years2
IDIP.PA Yearly Dividends per shareIDIP.PA Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

284.68% of the earnings are spent on dividend by IDIP. This is not a sustainable payout ratio.
IDIP's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP284.68%
EPS Next 2Y3.51%
EPS Next 3Y1.6%
IDIP.PA Yearly Income VS Free CF VS DividendIDIP.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M
IDIP.PA Dividend Payout.IDIP.PA Dividend Payout, showing the Payout Ratio.IDIP.PA Dividend Payout.PayoutRetained Earnings

IDI

EPA:IDIP (8/22/2025, 7:00:00 PM)

78.2

-1.2 (-1.51%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)03-26 2025-03-26/amc
Earnings (Next)09-24 2025-09-24
Inst Owners5.56%
Inst Owner ChangeN/A
Ins Owners0.39%
Ins Owner ChangeN/A
Market Cap562.26M
Analysts80
Price Target75.48 (-3.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.53%
Yearly Dividend7.82
Dividend Growth(5Y)32.69%
DP284.68%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-6.92%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.24%
EPS NY rev (3m)1.24%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)10.92%
Revenue NY rev (3m)10.92%
Valuation
Industry RankSector Rank
PE 28.64
Fwd PE 7.43
P/S 16.04
P/FCF N/A
P/OCF N/A
P/B 0.81
P/tB 0.81
EV/EBITDA 26.09
EPS(TTM)2.73
EY3.49%
EPS(NY)10.53
Fwd EY13.46%
FCF(TTM)-3.43
FCFYN/A
OCF(TTM)-3.42
OCFYN/A
SpS4.87
BVpS96.81
TBVpS96.1
PEG (NY)7.13
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.48%
ROE 2.81%
ROCE 2.18%
ROIC 1.6%
ROICexc 1.97%
ROICexgc 1.98%
OM 48.06%
PM (TTM) 55.88%
GM 79.62%
FCFM N/A
ROA(3y)6.91%
ROA(5y)8.52%
ROE(3y)8.14%
ROE(5y)10.26%
ROIC(3y)5.26%
ROIC(5y)6.74%
ROICexc(3y)6.97%
ROICexc(5y)7.85%
ROICexgc(3y)7.02%
ROICexgc(5y)7.88%
ROCE(3y)7.16%
ROCE(5y)9.17%
ROICexcg growth 3Y-48.28%
ROICexcg growth 5Y-15.73%
ROICexc growth 3Y-48.42%
ROICexc growth 5Y-15.87%
OM growth 3Y-18.32%
OM growth 5Y-8%
PM growth 3Y-13.5%
PM growth 5Y-3.2%
GM growth 3Y-6.56%
GM growth 5Y-3.38%
F-Score2
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA 3.18
Cap/Depr 6.49%
Cap/Sales 0.27%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.07
Quick Ratio 8.07
Altman-Z 4.84
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73%
EPS 3Y-46.57%
EPS 5Y-9.38%
EPS Q2Q%302.61%
EPS Next Y4.01%
EPS Next 2Y3.51%
EPS Next 3Y1.6%
EPS Next 5YN/A
Revenue 1Y (TTM)-60.84%
Revenue growth 3Y-37.88%
Revenue growth 5Y-6.78%
Sales Q2Q%45877.08%
Revenue Next Year15.53%
Revenue Next 2Y10.61%
Revenue Next 3Y-11.47%
Revenue Next 5YN/A
EBIT growth 1Y-76.38%
EBIT growth 3Y-49.26%
EBIT growth 5Y-14.24%
EBIT Next Year-82.61%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-44.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-62.71%
OCF growth 3YN/A
OCF growth 5YN/A